Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis

키워드

참고문헌 (29)

1. Levi M, "Disseminated intravascular coagulation", N Engl J Med, 341, pp.586~592 (1999)[DOI]
2. Levi M, "Guidelines for the diagnosis and management of disseminated intravascular coagulation: British Committee for Standards in Haematology", Br J Haematol, 145, pp.24~33 (2009)[DOI]
3. Yamakawa K, "Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis", Intensive Care Med, 39, pp.644~652 (2013)[DOI]
4. Ueno H, "Coagulation", fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure, 2002, pp.30, 2242~2248
5. Frossard JL, "Acute pancreatitis", Lancet, 371, pp.143~152 (2008)[DOI]
6. Higuchi R, "TG13 miscellaneous etiology of cholangitis and cholecystitis", J Hepatobiliary Pancreat Sci, 20, pp.97~105 (2013)[DOI]
7. Pang YY, "Predictors for emergency biliary decompression in acute cholangitis", Eur J Gastroenterol Hepatol, 18, pp.727~731 (2006)[DOI]
8. Agarwal N, "Endoscopic management of acute cholangitis in elderly patients", World J Gastroenterol, 12, pp.6551~6555 (2006)[DOI]
9. 염동한, "What Are the Risk Factors for Acute Suppurative Cholangitis Caused by Common Bile Duct Stones?", Gut and Liver, 4(3), pp.363~367 (2010), 거트앤리버 소화기연관학회협의회
10. Itoi T, "TG13 indications and techniques for biliary drainage in acute cholangitis (with videos)", J Hepatobiliary Pancreat Sci, 20, pp.71~80 (2013)[DOI]
11. Ogawa Y, "Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis", J Trauma Acute Care Surg, 72, pp.1150~1157 (2012)[DOI]
12. Abeyama K, "The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism", J Clin Invest, 115, pp.1267~1274 (2005)[DOI]
13. Eguchi T, "Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients", Pancreatology, 15, pp.485~490 (2015)[DOI]
14. Kawano N, "Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution: an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases", Intern Med, 53, pp.205~213 (2014)[DOI]
15. Yokoyama H, "Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum", Int J Hematol, 105, pp.606~613 (2017)[DOI]
16. Suetani K, "Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation", World J Gastroenterol, 21, pp.533~540 (2015)[DOI]
17. Kiriyama S, "TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)", J Hepatobiliary Pancreat Sci, 20, pp.24~34 (2013)[DOI]
18. Ogura T, "Technical tips of endoscopic ultrasound-guided choledochoduodenostomy", World J Gastroenterol, 21, pp.820~828 (2015)[DOI]
19. Ogura T, "Technical tips for endoscopic ultrasound-guided hepaticogastrostomy", World J Gastroenterol, 22, pp.3945~3951 (2016)[DOI]
20. Wada H, "Expert consensus for the treatment of disseminated intravascular coagulation in Japan", Thromb Res, 125, pp.6~11 (2010)[DOI]
21. Kaukonen KM, "Systemic inflammatory response syndrome criteria in defining severe sepsis", N Engl J Med, 372, pp.1629~1638 (2015)[DOI]
22. Aikawa N, "Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial", Shock, 35, pp.349~354 (2011)[DOI]
23. Cotton PB, "A lexicon for endoscopic adverse events: report of an ASGE workshop", Gastrointest Endosc, 71, pp.446~454 (2010)[DOI]
24. Thompson JE Jr, "Broad spectrum penicillin as an adequate therapy for acute cholangitis", Surg Gynecol Obstet, 171, pp.275~282 (1990)
25. Salek J, "Analysis of risk factors predictive of early mortality and urgent ERCP in acute cholangitis", J Clin Gastroenterol, 43, pp.171~175 (2009)[DOI]
26. Okamoto K, "Sepsis and disseminated intravascular coagulation", J Intensive Care, 4, pp.23~ (2016)[DOI]
27. Saito H, "Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial", J Thromb Haemost, 5, pp.31~41 (2007)[DOI]
28. Vincent JL, "A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation", Crit Care Med, 41, pp.2069~2079 (2013)[DOI]
29. Zhang C, "Recombinant human soluble thrombomodulin and short-term mortality of infection patients with DIC: a meta-analysis", Am J Emerg Med, 34, pp.1876~1882 (2016)[DOI]

관련 논문AI추천